Aproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia
A pesar de que la preeclampsia (PE) es una de las principales causas de morbimortalidad materna y fetal, su etiología es desconocida. Con el objetivo de determinar nuevos genes y mutaciones potencialmente etiológicos de la enfermedad, en el presente trabajo efectuamos la secuenciación simultánea de...
Autor Principal: | |
---|---|
Otros Autores: | |
Formato: | Tesis de maestría (Master Thesis) |
Lenguaje: | Español (Spanish) |
Publicado: |
Universidad del Rosario
2019
|
Materias: | |
Acceso en línea: | http://repository.urosario.edu.co/handle/10336/19110 |
id |
ir-10336-19110 |
---|---|
recordtype |
dspace |
institution |
EdocUR - Universidad del Rosario |
collection |
DSpace |
language |
Español (Spanish) |
topic |
Preeclampsia Marcadores moleculares Varias ramas de la medicina, Cirugía Preeclampsia Toxemia Genética humana |
spellingShingle |
Preeclampsia Marcadores moleculares Varias ramas de la medicina, Cirugía Preeclampsia Toxemia Genética humana Chaparro-Solano, HM Aproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia |
description |
A pesar de que la preeclampsia (PE) es una de las principales causas de morbimortalidad materna y fetal, su etiología es desconocida. Con el objetivo de determinar nuevos genes y mutaciones potencialmente etiológicos de la enfermedad, en el presente trabajo efectuamos la secuenciación simultánea de 386 genes, a partir de ADN placentario, en 60 mujeres afectadas por PE y restricción de crecimiento intrauterino (RCIU). Computacionalmente, utilizamos rigurosos filtros de selección de variantes. Identificamos 21 variantes (21 genes), entre las cuales 14 fueron confirmadas por medio de secuenciación de Sanger (AGT, ERAP1, F5, FOS, HTRA3, KDR, LIPC, MAN1C1, PDGFRA, SIAE, TET2, TGFB2, TGFB3, VCAN). Aquellos genes con variantes que participan en procesos biológicos como coagulación, modulación de la función inmunológica y angiogénesis llamaron especialmente la atención por su íntima relación con el desarrollo y función placentaria. Los resultados obtenidos son innovadores y sugieren una etiología poligénica de la PE. En el futuro, para una mejor comprensión de los resultados en el marco de la función placentaria, son imperativos estudios adicionales in vitro e in vivo. |
author2 |
Laissue, Paul |
author_facet |
Laissue, Paul Chaparro-Solano, HM |
format |
Tesis de maestría (Master Thesis) |
author |
Chaparro-Solano, HM |
author_sort |
Chaparro-Solano, HM |
title |
Aproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia |
title_short |
Aproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia |
title_full |
Aproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia |
title_fullStr |
Aproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia |
title_full_unstemmed |
Aproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia |
title_sort |
aproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia |
publisher |
Universidad del Rosario |
publishDate |
2019 |
url |
http://repository.urosario.edu.co/handle/10336/19110 |
_version_ |
1645141658125205504 |
spelling |
ir-10336-191102019-09-19T12:37:54Z Aproximación genómica a gran escala para la identificación de nuevos marcadores moleculares de preeclampsia Chaparro-Solano, HM Laissue, Paul Preeclampsia Marcadores moleculares Varias ramas de la medicina, Cirugía Preeclampsia Toxemia Genética humana A pesar de que la preeclampsia (PE) es una de las principales causas de morbimortalidad materna y fetal, su etiología es desconocida. Con el objetivo de determinar nuevos genes y mutaciones potencialmente etiológicos de la enfermedad, en el presente trabajo efectuamos la secuenciación simultánea de 386 genes, a partir de ADN placentario, en 60 mujeres afectadas por PE y restricción de crecimiento intrauterino (RCIU). Computacionalmente, utilizamos rigurosos filtros de selección de variantes. Identificamos 21 variantes (21 genes), entre las cuales 14 fueron confirmadas por medio de secuenciación de Sanger (AGT, ERAP1, F5, FOS, HTRA3, KDR, LIPC, MAN1C1, PDGFRA, SIAE, TET2, TGFB2, TGFB3, VCAN). Aquellos genes con variantes que participan en procesos biológicos como coagulación, modulación de la función inmunológica y angiogénesis llamaron especialmente la atención por su íntima relación con el desarrollo y función placentaria. Los resultados obtenidos son innovadores y sugieren una etiología poligénica de la PE. En el futuro, para una mejor comprensión de los resultados en el marco de la función placentaria, son imperativos estudios adicionales in vitro e in vivo. 2019-02-07 2019-02-20T15:18:25Z info:eu-repo/semantics/masterThesis info:eu-repo/semantics/acceptedVersion http://repository.urosario.edu.co/handle/10336/19110 spa info:eu-repo/semantics/openAccess application/pdf Universidad del Rosario Maestría en Ciencias con Énfasis en Genética Humana Escuela de Medicina y Ciencias de la Salud instname:Universidad del Rosario reponame:Repositorio Institucional EdocUR American College of Obstetricians and Gynecologists (Ed.). (2013). Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists. Recuperado de https://www.acog.org/~/media/Task%20Force%20and%20Work%20Group%20Reports/public/HypertensioninPregnancy.pdf Bahassi, E. M., & Stambrook, P. J. (2014). Next-generation sequencing technologies: breaking the sound barrier of human genetics. Mutagenesis, 29(5), 303–310. https://doi.org/10.1093/mutage/geu031 Bdolah, Y., Karumanchi, S. A., & Sachs, B. P. (2005). Recent advances in understanding of preeclampsia. Croatian Medical Journal, 46(5), 728–736 Berglund, E. C., Kiialainen, A., & Syvänen, A.-C. (2011). Next-generation sequencing technologies and applications for human genetic history and forensics. Investigative Genetics, 2, 23. https://doi.org/10.1186/2041-2223-2-23 Brinkman-Van der Linden, E. C. M., Hurtado-Ziola, N., Hayakawa, T., Wiggleton, L., Benirschke, K., Varki, A., & Varki, N. (2007). Human-specific expression of Siglec-6 in the placenta. Glycobiology, 17(9), 922–931. https://doi.org/10.1093/glycob/cwm065 Burton, G. J., & Jauniaux, E. (2015). What is the placenta? American Journal of Obstetrics and Gynecology, 213(4 Suppl), S6.e1, S6-8. https://doi.org/10.1016/j.ajog.2015.07.050 Burton, G. J., Jauniaux, E., & Charnock-Jones, D. S. (2010). The influence of the intrauterine environment on human placental development. The International Journal of Developmental Biology, 54(2–3), 303–312. https://doi.org/10.1387/ijdb.082764gb Caburet, S., Zavadakova, P., Ben-Neriah, Z., Bouhali, K., Dipietromaria, A., Charon, C., … Fellous, M. (2012). Genome-wide linkage in a highly consanguineous pedigree reveals two novel loci on chromosome 7 for non-syndromic familial Premature Ovarian Failure. PloS One, 7(3), e33412. https://doi.org/10.1371/journal.pone.0033412 Carlosama, C., Elzaiat, M., Patiño, L. C., Mateus, H. E., Veitia, R. A., & Laissue, P. (2017). A homozygous donor splice-site mutation in the meiotic gene MSH4 causes primary ovarian insufficiency. Human Molecular Genetics, 26(16), 3161–3166. https://doi.org/10.1093/hmg/ddx199 Carlosama, C., Patiño, L. C., Beau, I., Morel, A., Delemer, B., Young, J., … Laissue, P. (2018). A novel mutation in KHDRBS1 in a patient affected by primary ovarian insufficiency. Clinical Endocrinology. https://doi.org/10.1111/cen.13749 Casals, F., Idaghdour, Y., Hussin, J., & Awadalla, P. (2012). Next-generation sequencing approaches for genetic mapping of complex diseases. Journal of Neuroimmunology, 248(1–2), 10–22. https://doi.org/10.1016/j.jneuroim.2011.12.017 Castro, T., Mateus, H. E., Fonseca, D. J., Forero, D., Restrepo, C. M., Talero, C., … Laissue, P. (2013). Sequence analysis of the ADRA2A coding region in children affected by attention deficit hyperactivity disorder. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 34(12), 2219–2222. https://doi.org/10.1007/s10072-013-1569-4 Cha, J., Sun, X., & Dey, S. K. (2012). Mechanisms of implantation: strategies for successful pregnancy. Nature Medicine, 18(12), 1754–1767. https://doi.org/10.1038/nm.3012 Chaabane, C., Coen, M., & Bochaton-Piallat, M.-L. (2014). Smooth muscle cell phenotypic switch: implications for foam cell formation. Current Opinion in Lipidology, 25(5), 374–379. https://doi.org/10.1097/MOL.0000000000000113 Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., & Romero, R. (2014). Pre-eclampsia part 1: current understanding of its pathophysiology. Nature Reviews. Nephrology, 10(8), 466–480. https://doi.org/10.1038/nrneph.2014.102 Chen, C. W., Jaffe, I. Z., & Karumanchi, S. A. (2014). Pre-eclampsia and cardiovascular disease. Cardiovascular Research, 101(4), 579–586. https://doi.org/10.1093/cvr/cvu018 Chesley, L. C., Annitto, J. E., & Cosgrove, R. A. (1968). The familial factor in toxemia of pregnancy. Obstetrics and Gynecology, 32(3), 303–311. Cnattingius, S., Reilly, M., Pawitan, Y., & Lichtenstein, P. (2004). Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. American Journal of Medical Genetics. Part A, 130A(4), 365–371. https://doi.org/10.1002/ajmg.a.30257 Cross, J. C. (2000). Genetic insights into trophoblast differentiation and placental morphogenesis. Seminars in Cell & Developmental Biology, 11(2), 105–113. https://doi.org/10.1006/scdb.2000.0156 Cui, Y., Wang, W., Dong, N., Lou, J., Srinivasan, D. K., Cheng, W., … Wu, Q. (2012). Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature, 484(7393), 246–250. https://doi.org/10.1038/nature10897 Dawson, L. M., Parfrey, P. S., Hefferton, D., Dicks, E. L., Cooper, M. J., Young, D., & Marsden, P. A. (2002). Familial risk of preeclampsia in Newfoundland: a population-based study. Journal of the American Society of Nephrology: JASN, 13(7), 1901–1906. Delcour, C., Amazit, L., Patino, L. C., Magnin, F., Fagart, J., Delemer, B., … Beau, I. (2018). ATG7 and ATG9A loss-of-function variants trigger autophagy impairment and ovarian failure. Genetics in Medicine: Official Journal of the American College of Medical Genetics. https://doi.org/10.1038/s41436-018-0287-y Dempfle, A., & Loesgen, S. (2004). Meta-analysis of linkage studies for complex diseases: an overview of methods and a simulation study. Annals of Human Genetics, 68(Pt 1), 69–83. Diggle, C. P., Parry, D. A., Logan, C. V., Laissue, P., Rivera, C., Restrepo, C. M., … Bonthron, D. T. (2012). Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis. Human Mutation, 33(8), 1175–1181. https://doi.org/10.1002/humu.22111 Ducat, A., Doridot, L., Calicchio, R., Méhats, C., Vilotte, J.-L., Castille, J., … Vaiman, D. (2016). Endothelial cell dysfunction and cardiac hypertrophy in the STOX1 model of preeclampsia. Scientific Reports, 6, 19196. https://doi.org/10.1038/srep19196 Fisher, S. J. (2015). Why is placentation abnormal in preeclampsia? American Journal of Obstetrics and Gynecology, 213(4 Suppl), S115-122. https://doi.org/10.1016/j.ajog.2015.08.042 Fong, F. M., Sahemey, M. K., Hamedi, G., Eyitayo, R., Yates, D., Kuan, V., … Walton, R. T. (2014). Maternal genotype and severe preeclampsia: a HuGE review. American Journal of Epidemiology, 180(4), 335–345. https://doi.org/10.1093/aje/kwu151 Fonseca, D. J., Rojas, R. F., Vergara, J. I., Ríos, X., Uribe, C., Chávez, L., … Laissue, P. (2013). A severe familial phenotype of Ichthyosis Curth-Macklin caused by a novel mutation in the KRT1 gene. The British Journal of Dermatology, 168(2), 456–458. https://doi.org/10.1111/j.1365-2133.2012.11181.x Fonseca, Dora Janeth, Garzón, E., Lakhal, B., Braham, R., Ojeda, D., Elghezal, H., … Laissue, P. (2012). Screening for mutations of the FOXO4 gene in premature ovarian failure patients. Reproductive Biomedicine Online, 24(3), 339–341. https://doi.org/10.1016/j.rbmo.2011.11.017 Fonseca, Dora Janeth, Ojeda, D., Lakhal, B., Braham, R., Eggers, S., Turbitt, E., … Laissue, P. (2012). CITED2 mutations potentially cause idiopathic premature ovarian failure. Translational Research: The Journal of Laboratory and Clinical Medicine, 160(5), 384–388. https://doi.org/10.1016/j.trsl.2012.05.006 Fonseca, Dora Janeth, Ortega-Recalde, O., Esteban-Perez, C., Moreno-Ortiz, H., Patiño, L. C., Bermúdez, O. M., … Laissue, P. (2014). BMP15 c.-9C>G promoter sequence variant may contribute to the cause of non-syndromic premature ovarian failure. Reproductive Biomedicine Online, 29(5), 627–633. https://doi.org/10.1016/j.rbmo.2014.07.018 Fonseca, Dora Janeth, Patiño, L. C., Suárez, Y. C., de Jesús Rodríguez, A., Mateus, H. E., Jiménez, K. M., … Laissue, P. (2015). Next generation sequencing in women affected by nonsyndromic premature ovarian failure displays new potential causative genes and mutations. Fertility and Sterility, 104(1), 154-162.e2. https://doi.org/10.1016/j.fertnstert.2015.04.016 Fonseca, Dora Janeth, Prada, C. F., Siza, L. M., Angel, D., Gomez, Y. M., Restrepo, C. M., … Laissue, P. (2012). A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. American Journal of Medical Genetics. Part A, 158A(3), 689–693. https://doi.org/10.1002/ajmg.a.35215 Forbes, K., & Westwood, M. (2010). Maternal growth factor regulation of human placental development and fetal growth. The Journal of Endocrinology, 207(1), 1–16. https://doi.org/10.1677/JOE-10-0174 Forero, D. A., Wonkam, A., Wang, W., Laissue, P., López-Correa, C., Fernández-López, J. C., … Perry, G. (2016). Current needs for human and medical genomics research infrastructure in low and middle income countries. Journal of Medical Genetics, 53(7), 438–440. https://doi.org/10.1136/jmedgenet-2015-103631 Galvez, J. M., Restrepo, C. M., Contreras, N. C., Alvarado, C., Calderón-Ospina, C.-A., Peña, N., … Fonseca, D. J. (2018). Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients. Pharmacogenomics and Personalized Medicine, 11, 169–178. https://doi.org/10.2147/PGPM.S170515 Glotov, A. S., Kazakov, S. V., Vashukova, E. S., Pakin, V. S., Danilova, M. M., Nasykhova, Y. A., … Baranov, V. S. (2018). Targeted sequencing analysis of ACVR2A gene identifies novel risk variants associated with preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1–7. https://doi.org/10.1080/14767058.2018.1449204 Guo, G., Lade, J. A., Wilton, A. N., Moses, E. K., Grehan, M., Fu, Y., … Brennecke, S. P. (1999). Genetic susceptibility to pre-eclampsia and chromosome 7q36. Human Genetics, 105(6), 641–647. Harrison, G. A., Humphrey, K. E., Jones, N., Badenhop, R., Guo, G., Elakis, G., … Cooper, D. W. (1997). A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. American Journal of Human Genetics, 60(5), 1158–1167. Hayward, C., Livingstone, J., Holloway, S., Liston, W. A., & Brock, D. J. (1992). An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance. American Journal of Human Genetics, 50(4), 749–757. Inoue, I., Rohrwasser, A., Helin, C., Jeunemaitre, X., Crain, P., Bohlender, J., … Lalouel, J. M. (1995). A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. The Journal of Biological Chemistry, 270(19), 11430–11436. Janatpour, M. J., Utset, M. F., Cross, J. C., Rossant, J., Dong, J., Israel, M. A., & Fisher, S. J. (1999). A repertoire of differentially expressed transcription factors that offers insight into mechanisms of human cytotrophoblast differentiation. Developmental Genetics, 25(2), 146–157. https://doi.org/10.1002/(SICI)1520-6408(1999)25:2<146::AID-DVG9>3.0.CO;2-K Jarvenpaa, J., Vuoristo, J. T., Savolainen, E.-R., Ukkola, O., Vaskivuo, T., & Ryynanen, M. (2007). Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 23(6), 351–355. https://doi.org/10.1080/09513590701350291 Johnson, M. P., Fitzpatrick, E., Dyer, T. D., Jowett, J. B. M., Brennecke, S. P., Blangero, J., & Moses, E. K. (2007). Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Molecular Human Reproduction, 13(1), 61–67. https://doi.org/10.1093/molehr/gal095 Johnson, Roten, L., Dyer, T., East, C., Forsmo, S., Blangero, J., … Moses, E. K. (2009). The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations. Human Genetics, 126(5), 655–666. https://doi.org/10.1007/s00439-009-0714-x Kanasaki, K., Palmsten, K., Sugimoto, H., Ahmad, S., Hamano, Y., Xie, L., … Kalluri, R. (2008). Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature, 453(7198), 1117–1121. https://doi.org/10.1038/nature06951 Kryukov, G. V., Pennacchio, L. A., & Sunyaev, S. R. (2007). Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. American Journal of Human Genetics, 80(4), 727–739. https://doi.org/10.1086/513473 Laissue, P. (2015). Aetiological coding sequence variants in non-syndromic premature ovarian failure: From genetic linkage analysis to next generation sequencing. Molecular and Cellular Endocrinology, 411, 243–257. https://doi.org/10.1016/j.mce.2015.05.005 Laissue, P. (2018). The molecular complexity of primary ovarian insufficiency aetiology and the use of massively parallel sequencing. Molecular and Cellular Endocrinology, 460, 170–180. https://doi.org/10.1016/j.mce.2017.07.021 Laissue, P., Burgio, G., l’Hôte, D., Renault, G., Marchiol-Fournigault, C., Fradelizi, D., … Vaiman, D. (2009). Identification of Quantitative Trait Loci responsible for embryonic lethality in mice assessed by ultrasonography. The International Journal of Developmental Biology, 53(4), 623–629. https://doi.org/10.1387/ijdb.082613pl Laissue, P., Lakhal, B., Benayoun, B. A., Dipietromaria, A., Braham, R., Elghezal, H., … Veitia, R. A. (2009). Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. Journal of Medical Genetics, 46(7), 455–457. https://doi.org/10.1136/jmg.2008.065086 Laissue, P., Lakhal, B., Vatin, M., Batista, F., Burgio, G., Mercier, E., … Vaiman, D. (2016). Association of FOXD1 variants with adverse pregnancy outcomes in mice and humans. Open Biology, 6(10). https://doi.org/10.1098/rsob.160109 Laissue, P., L’hôte, D., Serres, C., & Vaiman, D. (2009). Mouse models for identifying genes modulating fertility parameters. Animal: An International Journal of Animal Bioscience, 3(1), 55–71. https://doi.org/10.1017/S1751731108003315 Laissue, P., Restrepo, C., & Ortiz, A. (2017). Improving the evaluation of milestones for students completing a clinical genetics elective. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 19(12). https://doi.org/10.1038/gim.2017.62 Lakhal, B., Laissue, P., Elghèzal, H., & Fellous, M. (2008). [Genetic analysis of premature ovarian failure: role of forkhead and TGF-beta genes]. Gynecologie, Obstetrique & Fertilite, 36(9), 862–871. https://doi.org/10.1016/j.gyobfe.2008.07.002 Lakhal, Besma, Laissue, P., Braham, R., Elghezal, H., Saâd, A., Fellous, M., & Veitia, R. A. (2009). A novel BMP15 variant, potentially affecting the signal peptide, in a familial case of premature ovarian failure. Clinical Endocrinology, 71(5), 752–753. https://doi.org/10.1111/j.1365-2265.2009.03571.x Lakhal, Besma, Laissue, P., Braham, R., Elghezal, H., Saâd, A., Fellous, M., & Veitia, R. A. (2010). BMP15 and premature ovarian failure: causal mutations, variants, polymorphisms? Clinical Endocrinology, 72(3), 425–426. https://doi.org/10.1111/j.1365-2265.2009.03651.x L’Hôte, D., Laissue, P., Serres, C., Montagutelli, X., Veitia, R. A., & Vaiman, D. (2010). Interspecific resources: a major tool for quantitative trait locus cloning and speciation research. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology, 32(2), 132–142. https://doi.org/10.1002/bies.200900027 Liang, M., Niu, J., Zhang, L., Deng, H., Ma, J., Zhou, W., … Chen, L. (2016). Gene expression profiling reveals different molecular patterns in G-protein coupled receptor signaling pathways between early- and late-onset preeclampsia. Placenta, 40, 52–59. https://doi.org/10.1016/j.placenta.2016.02.015 Maltepe, E., Bakardjiev, A. I., & Fisher, S. J. (2010). The placenta: transcriptional, epigenetic, and physiological integration during development. The Journal of Clinical Investigation, 120(4), 1016–1025. https://doi.org/10.1172/JCI41211 Mateus, H. E., Pérez, A. M., Mesa, M. L., Escobar, G., Gálvez, J. M., Montaño, J. I., … Laissue, P. (2017). A first description of the Colombian national registry for rare diseases. BMC Research Notes, 10(1), 514. https://doi.org/10.1186/s13104-017-2840-1 Maynard, S., Epstein, F. H., & Karumanchi, S. A. (2008). Preeclampsia and angiogenic imbalance. Annual Review of Medicine, 59, 61–78. https://doi.org/10.1146/annurev.med.59.110106.214058 McMaster, M. T., Librach, C. L., Zhou, Y., Lim, K. H., Janatpour, M. J., DeMars, R., … Fisher, S. J. (1995). Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. Journal of Immunology (Baltimore, Md.: 1950), 154(8), 3771–3778. Miranda-Fernández, M.-C., Ramírez-Oyaga, S., Restrepo, C. M., Huertas-Quiñones, V.-M., Barrera-Castañeda, M., Quero, R., … Cabrera, R. (2018). Identification of a New Candidate Locus for Ebstein Anomaly in 1p36.2. Molecular Syndromology, 9(3), 164–169. https://doi.org/10.1159/000488820 Mitropoulos, K., Al Jaibeji, H., Forero, D. A., Laissue, P., Wonkam, A., Lopez-Correa, C., … Patrinos, G. P. (2015). Success stories in genomic medicine from resource-limited countries. Human Genomics, 9, 11. https://doi.org/10.1186/s40246-015-0033-3 Morales-Prieto, D. M., Chaiwangyen, W., Ospina-Prieto, S., Schneider, U., Herrmann, J., Gruhn, B., & Markert, U. R. (2012). MicroRNA expression profiles of trophoblastic cells. Placenta, 33(9), 725–734. https://doi.org/10.1016/j.placenta.2012.05.009 Moses, E. K., Lade, J. A., Guo, G., Wilton, A. N., Grehan, M., Freed, K., … Brennecke, S. P. (2000). A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. American Journal of Human Genetics, 67(6), 1581–1585. https://doi.org/10.1086/316888 Murthi, P., Kalionis, B., Cocquebert, M., Rajaraman, G., Chui, A., Keogh, R. J., … Fournier, T. (2013). Homeobox genes and down-stream transcription factor PPARγ in normal and pathological human placental development. Placenta, 34(4), 299–309. https://doi.org/10.1016/j.placenta.2013.01.005 Niño, M. Y., Mateus, H. E., Fonseca, D. J., Kroos, M. A., Ospina, S. Y., Mejía, J. F., … Laissue, P. (2013). Identification and Functional Characterization of GAA Mutations in Colombian Patients Affected by Pompe Disease. JIMD Reports, 7, 39–48. https://doi.org/10.1007/8904_2012_138 Ogden, E., Hildebrand, G. J., & Page, E. W. (1940). Rise of Blood Pressure During Ischemia of the Gravid Uterus. Proceedings of the Society for Experimental Biology and Medicine, 43(1), 49–51. https://doi.org/10.3181/00379727-43-11091P Ojeda, D., Lakhal, B., Fonseca, D. J., Braham, R., Landolsi, H., Mateus, H. E., … Laissue, P. (2011). Sequence analysis of the CDKN1B gene in patients with premature ovarian failure reveals a novel mutation potentially related to the phenotype. Fertility and Sterility, 95(8), 2658-2660.e1. https://doi.org/10.1016/j.fertnstert.2011.04.045 Ortega-Recalde, O., Beltrán, O. I., Gálvez, J. M., Palma-Montero, A., Restrepo, C. M., Mateus, H. E., & Laissue, P. (2015). Biallelic HERC1 mutations in a syndromic form of overgrowth and intellectual disability. Clinical Genetics, 88(4), e1-3. https://doi.org/10.1111/cge.12634 Ortega-Recalde, O., Moreno, M. B., Vergara, J. I., Fonseca, D. J., Rojas, R. F., Mosquera, H., … Laissue, P. (2015). A novel TGM1 mutation, leading to multiple splicing rearrangements, is associated with autosomal recessive congenital ichthyosis. Clinical and Experimental Dermatology, 40(7), 757–760. https://doi.org/10.1111/ced.12627 Ortega-Recalde, O., Silgado, D., Fetiva, C., Fonseca, D. J., & Laissue, P. (2016). Transcriptomic analysis of skin in a case of ichthyosis Curth-Macklin caused by a KRT1 mutation. The British Journal of Dermatology, 175(6), 1372–1375. https://doi.org/10.1111/bjd.14969 Ortega-Recalde, Oscar, Fonseca, D. J., Patiño, L. C., Atuesta, J. J., Rivera-Nieto, C., Restrepo, C. M., … Laissue, P. (2013). A novel familial case of diffuse leukodystrophy related to NDUFV1 compound heterozygous mutations. Mitochondrion, 13(6), 749–754. https://doi.org/10.1016/j.mito.2013.03.010 Ortega-Recalde, Oscar, Vergara, J. I., Fonseca, D. J., Ríos, X., Mosquera, H., Bermúdez, O. M., … Laissue, P. (2014). Whole-exome sequencing enables rapid determination of xeroderma pigmentosum molecular etiology. PloS One, 8(6), e64692. https://doi.org/10.1371/journal.pone.0064692 Patiño, Liliana C., Beau, I., Morel, A., Delemer, B., Young, J., Binart, N., & Laissue, P. (2019). Functional evidence implicating NOTCH2 missense mutations in primary ovarian insufficiency etiology. Human Mutation, 40(1), 25–30. https://doi.org/10.1002/humu.23667 Patiño, Liliana C., Walton, K. L., Mueller, T. D., Johnson, K. E., Stocker, W., Richani, D., … Harrison, C. A. (2017). BMP15 Mutations Associated With Primary Ovarian Insufficiency Reduce Expression, Activity, or Synergy With GDF9. The Journal of Clinical Endocrinology and Metabolism, 102(3), 1009–1019. https://doi.org/10.1210/jc.2016-3503 Patiño, Liliana Catherine, Battu, R., Ortega-Recalde, O., Nallathambi, J., Anandula, V. R., Renukaradhya, U., & Laissue, P. (2014). Exome sequencing is an efficient tool for variant late-infantile neuronal ceroid lipofuscinosis molecular diagnosis. PloS One, 9(10), e109576. https://doi.org/10.1371/journal.pone.0109576 Patiño, Liliana Catherine, Beau, I., Carlosama, C., Buitrago, J. C., González, R., Suárez, C. F., … Laissue, P. (2017). New mutations in non-syndromic primary ovarian insufficiency patients identified via whole-exome sequencing. Human Reproduction (Oxford, England), 32(7), 1512–1520. https://doi.org/10.1093/humrep/dex089 Patiño, Liliana Catherine, Silgado, D., & Laissue, P. (2017). A potential functional association between mutant BMPR2 and primary ovarian insufficiency. Systems Biology in Reproductive Medicine, 63(3), 145–149. https://doi.org/10.1080/19396368.2017.1291767 Plaks, V., Rinkenberger, J., Dai, J., Flannery, M., Sund, M., Kanasaki, K., … Werb, Z. (2013). Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proceedings of the National Academy of Sciences of the United States of America, 110(27), 11109–11114. https://doi.org/10.1073/pnas.1309561110 Prada, C. F., & Laissue, P. (2014). A high resolution map of mammalian X chromosome fragile regions assessed by large-scale comparative genomics. Mammalian Genome: Official Journal of the International Mammalian Genome Society, 25(11–12), 618–635. https://doi.org/10.1007/s00335-014-9537-8 Quail, M. A., Smith, M., Coupland, P., Otto, T. D., Harris, S. R., Connor, T. R., … Gu, Y. (2012). A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 13, 341. https://doi.org/10.1186/1471-2164-13-341 Quintero-Ronderos, P., & Laissue, P. (2018). The multisystemic functions of FOXD1 in development and disease. Journal of Molecular Medicine (Berlin, Germany), 96(8), 725–739. https://doi.org/10.1007/s00109-018-1665-2 Quintero-Ronderos, P., Mercier, E., Fukuda, M., González, R., Suárez, C. F., Patarroyo, M. A., … Laissue, P. (2017). Novel genes and mutations in patients affected by recurrent pregnancy loss. PloS One, 12(10), e0186149. https://doi.org/10.1371/journal.pone.0186149 Quintero-Ronderos, P., Mercier, E., Gris, J.-C., Esteban-Perez, C., Moreno-Ortiz, H., Fonseca, D. J., … Laissue, P. (2017). THBD sequence variants potentially related to recurrent pregnancy loss. Reproductive Biology and Endocrinology: RB&E, 15(1), 92. https://doi.org/10.1186/s12958-017-0311-0 Rabaglino, M. B., Post Uiterweer, E. D., Jeyabalan, A., Hogge, W. A., & Conrad, K. P. (2015). Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia. Hypertension (Dallas, Tex.: 1979), 65(2), 421–429. https://doi.org/10.1161/HYPERTENSIONAHA.114.04481 Rajagopalan, S., & Long, E. O. (1999). A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. The Journal of Experimental Medicine, 189(7), 1093–1100 Roten, L. T., Johnson, M. P., Forsmo, S., Fitzpatrick, E., Dyer, T. D., Brennecke, S. P., … Austgulen, R. (2009). Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). European Journal of Human Genetics: EJHG, 17(2), 250–257. https://doi.org/10.1038/ejhg.2008.158 Sarker, S., Scholz-Romero, K., Perez, A., Illanes, S. E., Mitchell, M. D., Rice, G. E., & Salomon, C. (2014). Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy. Journal of Translational Medicine, 12, 204. https://doi.org/10.1186/1479-5876-12-204 Schmidt, A., Morales-Prieto, D. M., Pastuschek, J., Fröhlich, K., & Markert, U. R. (2015). Only humans have human placentas: molecular differences between mice and humans. Journal of Reproductive Immunology, 108, 65–71. https://doi.org/10.1016/j.jri.2015.03.001 Sitras, V., Paulssen, R. H., Grønaas, H., Leirvik, J., Hanssen, T. A., Vårtun, A., & Acharya, G. (2009). Differential placental gene expression in severe preeclampsia. Placenta, 30(5), 424–433. https://doi.org/10.1016/j.placenta.2009.01.012 Skjaerven, R., Vatten, L. J., Wilcox, A. J., Rønning, T., Irgens, L. M., & Lie, R. T. (2005). Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ (Clinical Research Ed.), 331(7521), 877. https://doi.org/10.1136/bmj.38555.462685.8F Takimoto, E., Ishida, J., Sugiyama, F., Horiguchi, H., Murakami, K., & Fukamizu, A. (1996). Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science (New York, N.Y.), 274(5289), 995–998. Than, N. G., Romero, R., Kim, C. J., McGowen, M. R., Papp, Z., & Wildman, D. E. (2012). Galectins: guardians of eutherian pregnancy at the maternal-fetal interface. Trends in Endocrinology and Metabolism: TEM, 23(1), 23–31. https://doi.org/10.1016/j.tem.2011.09.003 Trapnell, C., & Salzberg, S. L. (2009). How to map billions of short reads onto genomes. Nature Biotechnology, 27(5), 455–457. https://doi.org/10.1038/nbt0509-455 Valero-Rubio, D., Jiménez, K. M., Fonseca, D. J., Payán-Gómez, C., & Laissue, P. (2018). Transcriptomic analysis of FUCA1 knock-down in keratinocytes reveals new insights into the pathogenesis of fucosidosis skin lesions. Experimental Dermatology, 27(6), 663–667. https://doi.org/10.1111/exd.13532 van Dijk, M., Mulders, J., Poutsma, A., Könst, A. A. M., Lachmeijer, A. M. A., Dekker, G. A., … Oudejans, C. B. M. (2005). Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nature Genetics, 37(5), 514–519. https://doi.org/10.1038/ng1541 Vatin, M., Bouvier, S., Bellazi, L., Montagutelli, X., Laissue, P., Ziyyat, A., … Gris, J.-C. (2014). Polymorphisms of human placental alkaline phosphatase are associated with in vitro fertilization success and recurrent pregnancy loss. The American Journal of Pathology, 184(2), 362–368. https://doi.org/10.1016/j.ajpath.2013.10.024 Vatin, M., Burgio, G., Renault, G., Laissue, P., Firlej, V., Mondon, F., … Ziyyat, A. (2012). Refined Mapping of a Quantitative Trait Locus on Chromosome 1 Responsible for Mouse Embryonic Death. PloS One, 7(8), e43356. https://doi.org/10.1371/journal.pone.0043356 Williams, P. J., & Broughton Pipkin, F. (2011). The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Practice & Research. Clinical Obstetrics & Gynaecology, 25(4), 405–417. https://doi.org/10.1016/j.bpobgyn.2011.02.007 Winn, V. D., Gormley, M., & Fisher, S. J. (2011). The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface. Pregnancy Hypertension, 1(1), 100–108. https://doi.org/10.1016/j.preghy.2010.12.001 Zhou, Y., Genbacev, O., & Fisher, S. J. (2003). The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Annals of the New York Academy of Sciences, 995, 73–83. Zintzaras, E., Kitsios, G., Harrison, G. A., Laivuori, H., Kivinen, K., Kere, J., … Ioannidis, J. P. A. (2006). Heterogeneity-based genome search meta-analysis for preeclampsia. Human Genetics, 120(3), 360–370. https://doi.org/10.1007/s00439-006-0214-1 |
score |
12,131701 |